Document:

Commitment Letter dated September 7, 2008

 Exhibit 10.1 
 EXECUTION COPY 
  

			
	JPMORGAN CHASE BANK, N.A.	 	GOLDMAN SACHS CREDIT PARTNERS L.P.
	J.P. MORGAN SECURITIES INC.	 	GOLDMAN SACHS BANK USA
	270 Park Avenue	 	85 Broad Street
	New York, NY 10017	 	New York, New York 10004

 September 7, 2008 
 Project Table 
 Commitment Letter 
 Altria Group, Inc. 
 6601 West Broad Street 
 Richmond, Virginia 23230 
 Attention: Mr. William F. Gifford, Vice President and Treasurer 
 Ladies and Gentlemen: 
 Altria Group, Inc., a Virginia
corporation (“Altria” or “you”), has advised J.P. Morgan Securities Inc. (“JPM”), JPMorgan Chase Bank, N.A. (“JPMCB”), Goldman Sachs Credit Partners L.P. (“GSCP”
and, together with JPM, in their capacities as arrangers, the “Joint Lead Arrangers”) and Goldman Sachs Bank USA (“GSB” and, together with GSCP and JPMCB, in their capacities as Lenders (as defined herein), the
“Initial Lenders”), that it intends to acquire all of the outstanding capital stock of UST Inc. (“Target”) pursuant to an agreement (the “Merger Agreement”) under which a newly created, wholly-owned
subsidiary of Altria will merge into Target (the “Acquisition”), and has requested that the Joint Lead Arrangers agree to structure and arrange a senior 364-day bridge loan facility in an aggregate amount of US$7,000,000,000 (the
“New Bridge Facility”) to provide a portion of the financing for the Acquisition and related transactions. You have also requested that each of JPMCB, GSCP and GSB commit to provide a portion of the New Bridge Facility, that JPMCB
and GSCP consent, in their capacity as lenders under the US$4,000,000,000 364-Day Bridge Loan Agreement dated as of January 28, 2008 (the “Existing Bridge Facility”), among Altria and the agents and lenders parties thereto, to
the amendments described in Exhibit B hereto, including the provisions relating to the extension of their commitments thereunder, and that JPMCB and William Street Commitment Corporation, an affiliate of GSCP, consent, in their capacity as lenders
under the 5-Year Revolving Credit Agreement dated as of April 15, 2005 (the “5-Year Revolver”), among Altria and the agents and lenders parties thereto, to the amendments described in Exhibit C hereto (collectively, the
“Amendments”). 
 The Joint Lead Arrangers are pleased to advise you that they are willing to act as joint lead arrangers
and bookrunners for the New Bridge Facility. 
 Furthermore, (a) JPMCB is pleased to advise you of its commitment to provide
US$3,500,000,000 of the New Bridge Facility and consent to the Amendments, (b) GSCP is 

 
pleased to advise you of its commitment to provide US$3,165,000,000 of the New Bridge Facility and to consent to the amendments to the Existing Bridge
Facility described in Exhibit B hereto, (c) GSB is pleased to advise you of its commitment to provide US$335,000,000 of the New Bridge Facility and (d) William Street Commitment Corporation is pleased to advise you of its commitment,
solely in its capacity as a lender under the 5-Year Revolver, to consent to the amendments to the 5-Year Revolver described in Exhibit C hereto, in each case, upon the terms and subject to the conditions set forth or referred to in this commitment
letter (the “Commitment Letter”) and in the applicable Summary of Terms and Conditions attached hereto as Exhibit A, Exhibit B and Exhibit C (collectively, the “Term Sheets”). It is understood that the commitments
of the Initial Lenders under the New Bridge Facility will be reduced as provided under “Reduction, Cancellation or Prepayment: Mandatory Prepayment” in Exhibit A hereto. 
 It is agreed that JPMCB and GSCP will act as the administrative agents, and that the Joint Lead Arrangers will act as the exclusive joint lead arrangers
and bookrunners, for the New Bridge Facility, and each will, in such capacities, perform the duties and exercise the authority customarily performed and exercised by it in such roles (it being understood that JPMCB alone will perform the duties and
exercise the authority customarily performed and exercised by an administrative agent). It is agreed that JPMorgan will have “left placement” in the Confidential Information Memorandum and any other marketing materials or advertisements
relating to the New Bridge Facility. 
 We understand that you intend to refinance the New Bridge Facility with one or more offerings of
your debt securities. In the event you determine that the New Bridge Facility or a portion thereof cannot or should not be refinanced or replaced by such an offering of securities and you elect to refinance or replace it with any credit or similar
facilities (“Replacement Facilities”), you hereby agree that you will offer the Joint Lead Arrangers the opportunity to be the exclusive joint lead arrangers and bookrunners, respectively, for any such Replacement Facilities
arranged by or on behalf of you or any of your subsidiaries (including Target or its subsidiaries), whether such facilities are established prior to, on or after the date on which the Acquisition is consummated (the “Closing Date”).
You acknowledge and agree that the engagement of the Joint Lead Arrangers hereunder shall not constitute or give rise to any obligation to provide or arrange any Replacement Facility, it being agreed that any such obligation that they may hereafter
undertake would be set forth in a commitment letter to be entered into by you and the Joint Lead Arrangers. 
 We intend to syndicate the
New Bridge Facility to a group of financial institutions (the “Lenders”) selected as provided below. The Joint Lead Arrangers intend to commence syndication efforts promptly, and you agree actively to assist the Joint Lead Arrangers
in completing a successful syndication (as defined in the Fee Letters). Such assistance shall include (a) your using commercially reasonable efforts to ensure that the syndication efforts benefit materially from your existing lending
relationships, (b) as necessary and to the extent mutually agreed upon, direct contact between appropriate senior management and advisors of Altria and the proposed lenders (and your endeavoring, without being required to initiate any
enforcement action, to arrange such contact between Target’s appropriate senior management and advisors and the proposed lenders, to the extent Target is obligated under the Merger Agreement to make such senior management and advisors available
to facilitate the syndication), (c) your assistance (including your endeavoring, without being required to initiate any enforcement action, to arrange for Target and its advisors to assist, to the extent Target is obligated under the Merger

  

 2 

 
Agreement to provide such assistance to facilitate the syndication) in the preparation of Confidential Information Memoranda and other marketing materials to
be used in connection with the syndication (collectively, “Information Materials”) and (d) the hosting, with the Joint Lead Arrangers, of one or two conference calls with prospective Lenders at times to be mutually agreed and,
if each of the Joint Lead Arrangers determines and advises you that it would be advisable in order to facilitate a successful syndication, a meeting for potential Lenders. You agree to afford the Joint Lead Arrangers a period of at least 30 days
from the launch of the General Syndication to syndicate the New Bridge Facility. In addition, to facilitate an orderly and successful syndication of the New Bridge Facility, you agree that, until the earlier of the completion of a successful
syndication and 60 days following the date of effectiveness of the New Bridge Facility, you and your subsidiaries will not syndicate or issue, attempt to syndicate or issue or announce the syndication or issuance of any debt facility or any
debt or equity-linked security of Altria or its subsidiaries (other than any such offering or placement of debt securities to refinance or replace the New Bridge Facility or the Existing Bridge Facility and any issuance of commercial paper, it being
understood that nothing herein shall prevent you from borrowing under the Existing Bridge Facility or the 5-Year Revolver). 
 It is
contemplated that following the public announcement of your agreement to acquire Target, and prior to the general syndication of the Facility (the “General Syndication”), the Initial Lenders may assign portions of their commitments
hereunder to one or more of the financial institutions heretofore agreed upon by you and us (or any other financial institution subsequently identified by us and approved by you) (the solicitation of and assignments to such financial institutions
prior to the General Syndication being referred to as the “Initial Syndication”, and any such financial institution to which such an assignment is made before the commencement of the General Syndication being referred to as an
“Additional Initial Lender”), and that upon any such assignment the Initial Lenders shall be released from the portions of their commitments so assigned. It is agreed that, after giving effect to all assignments made as part of the
Initial Syndication, (a) JPMCB on the one hand, and GSCP and GSB on the other, will have equal commitments in respect of the New Bridge Facility and (b) no institution will have a commitment in excess of the commitment of JPMCB or the
aggregate commitments of GSCP and GSB without your consent. In connection with any such assignments, you agree, at the request of the Initial Lenders, that you will enter into appropriate documentation (including, if requested by the Initial Lenders
or by you, joinder agreements under which the Additional Initial Lenders become parties to this Commitment Letter and extend commitments directly to you) containing such provisions relating to the allocation of titles, rights and responsibilities in
connection with the Initial Syndication of the New Bridge Facility and compensation as the Initial Lenders shall request (but which will not, except as agreed by you, add any conditions to the availability of the New Bridge Facility or change the
terms of the New Bridge Facility or the compensation payable by you in connection therewith as set forth in the Term Sheet and in the Fee Letters). 
 The Joint Lead Arrangers will, in consultation with you, manage all aspects of the syndication of the New Bridge Facility in accordance with the terms hereof and of the Fee Letters, including decisions as to the
selection of institutions to be approached and when they will be approached, when their commitments will be accepted, which institutions will participate, the allocations of the commitments among the Lenders and the amount and distribution of fees
among the Lenders. It is agreed that all such decisions, including decisions as to institutions to be approached, shall be made in a manner consistent with the syndication strategy agreed upon 

  

 3 

 
by you and us prior to the date hereof, except to the extent we determine, after consultation with you, that changes from such strategy are advisable to
facilitate a successful syndication. To assist the Joint Lead Arrangers in their syndication efforts, you agree promptly to prepare and provide to them such information with respect to Altria and Target, including financial information, as they may
reasonably request in connection with the arrangement and syndication of the New Bridge Facility, it being understood that any financial information requested in addition to the financial information provided to the Joint Lead Arrangers prior to the
date hereof shall be mutually agreed to by the Joint Lead Arrangers and you. 
 You hereby represent and covenant that (a) all
information (other than projections, forecasts, budgets, estimates and other forward-looking statements (collectively, the “Projections”) and information of a general economic or industry specific nature) that has been or will be
made available to the Joint Lead Arrangers or the Initial Lenders by you or any of your representatives (the “Information”), when taken as a whole with other Information then or heretofore made available, is or will, when furnished,
be complete and correct in all material respects and does not or will not, when furnished, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein not materially
misleading in light of the circumstances under which such statements are made and (b) the Projections that have been or will be made available to us or any of the Lenders by or on behalf of you in connection with the transactions contemplated
hereby have been (or, in the case of Projections prepared after the date hereof, will be) prepared in good faith based upon assumptions believed by you to be reasonable at the time of preparation thereof (it being understood that projections by
their nature are inherently uncertain and no assurances are being given that the results reflected in the Projections will be achieved); provided that, with respect to any Information or Projections prepared by Target, such representation and
warranty is made only to your knowledge. You agree that if at any time prior to the earlier of the completion of a successful syndication and 60 days following the date of effectiveness of the New Bridge Facility the representation and warranty
in the immediately preceding sentence would not be true if the Information and Projections were being furnished and such representation and warranty were being made at such time, then you will promptly supplement the Information and the Projections
so that such representation or warranty would be true under those circumstances. You understand that in connection with the New Bridge Facility and the Amendments we may use and rely on the Information without independent verification thereof.

 The Initial Lenders’ commitments hereunder and the Joint Lead Arrangers’ agreements to perform the services described herein
are subject to (a) there not having occurred or become known to the Initial Lenders and the Joint Lead Arrangers any material adverse change in the financial condition or operations of Altria and its subsidiaries, taken as a whole (other than a
material adverse change related to litigation against Altria or any of its subsidiaries) since December 31, 2007, except as disclosed in Altria’s Annual Report on Form 10-K for the year ended December 31, 2007, Quarterly Reports on
Form 10-Q for the quarters ended March 31, 2008 and June 30, 2008, and in any Current Report on Form 8-K filed subsequent to June 30, 2008 but prior to the date hereof, and there not having occurred any “Company Material Adverse
Effect”, as defined in the Merger Agreement (but only to the extent you would have the right under the Merger Agreement not to consummate the Acquisition), (b) the negotiation, execution and delivery on or before the End Date, as defined
below (or such other date as may be mutually agreed among the parties hereto), of definitive documentation with respect to the New Bridge Facility satisfactory to the Initial Lenders and their counsel, (c) the payment of fees pursuant to

  

 4 

 
the Fee Letters and the performance by you of your other material obligations hereunder and under the Fee Letters, and (d) the other conditions set
forth or referred to in the Term Sheets. This Commitment Letter may be terminated by you at any time at your option upon payment of all fees, expenses and other amounts then payable hereunder. As used herein, “End Date” shall mean the nine
month anniversary of the date of the Merger Agreement or such later date (but not later than the twelve month anniversary of the date of the Merger Agreement) to which such “End Date” shall be extended in accordance with
Section 8.2(a) of the Merger Agreement (Draft of 9/5/08) as heretofore furnished to us. 
 As consideration for the Initial
Lenders’ commitments hereunder and our agreements to perform the services described herein, you agree to pay to us the fees as set forth in the fee letters dated the date hereof and delivered herewith (the “Fee Letters”).

 You agree (a) to indemnify and hold harmless the Joint Lead Arrangers, the Initial Lenders, their respective affiliates and their
respective officers, directors, employees, advisors, and agents (each, an “indemnified person”) from and against any and all losses, claims, damages and liabilities to which any such indemnified person may become subject arising out
of or in connection with this Commitment Letter, the New Bridge Facility, the use of the proceeds thereof, the Amendments or any claim, litigation, investigation or proceeding relating to any of the foregoing, regardless of whether any indemnified
person is a party thereto, and to reimburse each indemnified person upon demand for any legal or other expenses incurred in connection with investigating or defending any of the foregoing; provided that the foregoing indemnity will not, as to
any indemnified person, apply to losses, claims, damages, liabilities or related expenses to the extent they are found by a final, non-appealable judgment of a court to arise from the willful misconduct, bad faith or gross negligence of such
indemnified person, and (b) to reimburse the Joint Lead Arrangers, the Initial Lenders and their respective affiliates on demand for all reasonable out-of-pocket expenses (including (x) due diligence expenses and (y) reasonable fees,
charges and disbursements of a single counsel incurred in connection with the New Bridge Facility, the Amendments and any related documentation (including this Commitment Letter, the Term Sheets and the definitive financing documentation);
provided that upon receipt by an indemnified person of notice of any such matter, such indemnified person shall promptly notify you with respect thereto. Notwithstanding the foregoing, your obligation to pay legal fees and expenses under
clause (a) of the preceding sentence will be subject to the conditions that: (i) you shall not be responsible for the fees and expenses of more than one such separate counsel (and, where appropriate, local counsel) for all indemnified
persons in any single matter; and (ii) you shall not be obligated to reimburse any indemnified person in advance of a final determination of such matter unless such indemnified person agrees in writing to remit such amounts to you in the event
that it is ultimately determined in respect of such matter that the indemnified person was guilty of gross negligence, bad faith or willful misconduct. Failure by an indemnified person to provide the notice required above shall not relieve you of
your responsibilities to such indemnified person hereunder except to the extent you are prejudiced by such failure. You shall have no liability for any settlement effected without your written consent. The parties hereto agree that information and
materials may be distributed or sent through electronic means (including IntraLinks) and that the use of such means is expressly authorized hereby and that no party hereto shall be responsible for the misuse of any such information or other
materials by unauthorized recipients thereof. In addition, no party hereto shall be liable for any special, indirect, consequential or punitive damages in connection with the New Bridge Facility or the Amendments. 
  

 5 

 You acknowledge that the Joint Lead Arrangers, the Initial Lenders and their affiliates (the terms
“Joint Lead Arrangers” and “Initial Lenders” as used below in this paragraph being understood to include such affiliates) may be providing debt financing, equity capital or other services (including financial advisory services)
to other companies in respect of which you or Target may have conflicting interests. Neither the Joint Lead Arrangers nor the Initial Lenders will use confidential information obtained from you by virtue of the transactions contemplated hereby or
their other relationships with you in connection with the performance by them of services for other companies, and neither the Joint Lead Arrangers nor the Initial Lenders will furnish any such information to other companies. You also acknowledge
that neither the Joint Lead Arrangers nor the Initial Lenders have any obligation to use in connection with the transactions contemplated hereby, or to furnish to you, confidential information obtained from other companies. Each Joint Lead Arranger
and Initial Lender acknowledges and agrees that it will comply with the confidentiality agreement attached hereto as Schedule 1. 
 This Commitment Letter shall not be assignable by you without the prior written consent of the Joint Lead Arrangers and the Initial Lenders (and any purported assignment without such consent shall be null and void), is intended to be solely
for the benefit of the parties hereto and is not intended to confer any benefits upon, or create any rights in favor of, or be enforceable by or at the request of, any person other than the parties hereto and the indemnified persons. This Commitment
Letter may not be amended or waived except by an instrument in writing signed by you, the Joint Lead Arrangers and the Initial Lenders. This Commitment Letter may be executed in any number of counterparts, each of which shall be an original, and all
of which, when taken together, shall constitute one agreement. Delivery of an executed signature page of this Commitment Letter by facsimile transmission shall be effective as delivery of a manually executed counterpart hereof. This Commitment
Letter and the Fee Letters are the only agreements that have been entered into among us with respect to the New Bridge Facility and the Amendments and set forth the entire understanding of the parties with respect thereto. This Commitment Letter
shall be governed by, and construed in accordance with, the laws of the State of New York. Any legal action or proceeding arising out of or related to this Commitment Letter or the Fee Letters may be brought in the courts of the State of New York or
of the United States of America for the Southern District of New York, and by execution and delivery of this Commitment Letter, the parties hereto hereby consent to the non-exclusive jurisdiction of the aforesaid courts. EACH PARTY HERETO HEREBY
WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS COMMITMENT LETTER, THE FEE LETTERS OR THE TRANSACTIONS CONTEMPLATED
HEREBY. 
 This Commitment Letter is delivered to you on the understanding that none of this Commitment Letter, the Term Sheet, the Fee
Letters or any of their terms or substance shall be disclosed, directly or indirectly, to any other person, except that (a) this Commitment Letter, the Term Sheet, the Fee Letters and their terms and substance may be disclosed (i) to your
affiliates, directors, officers, employees, agents, auditors, attorneys and other advisors and representatives who are directly involved in the consideration of this matter or (ii) as may be compelled in a judicial or administrative proceeding
or as otherwise required by law (in which case you agree to inform us promptly thereof), (b) following your acceptance of this Commitment Letter and of the Fee Letters, this Commitment Letter, the Term Sheet and the terms and substance hereof
and thereof (but not the Fee Letters or the terms or substance thereof) may be disclosed to Target or 

  

 6 

 
in one or more filings with the Securities and Exchange Commission and (c) in connection with the Initial Syndication, the fees to be paid to the
Additional Initial Lenders may be disclosed to potential Additional Initial Lenders, and in connection with the General Syndication, the fees to be paid to Lenders assuming commitments in the General Syndication may be disclosed to potential
Lenders. 
 You agree that neither this Commitment Letter nor our activities contemplated hereby will be deemed to create an advisory,
fiduciary or agency relationship or fiduciary or other implied duty between us, on the one hand, and you or your subsidiaries, affiliates or stockholders, on the other. 
 The reimbursement, indemnification and confidentiality provisions contained herein and in Schedule 1 shall remain in full force and effect regardless of whether definitive financing documentation shall be executed and
delivered and notwithstanding the termination of this Commitment Letter or the Initial Lenders’ commitments hereunder. In addition, if a successful syndication of the New Bridge Facility shall not have been completed, the provisions contained
herein with respect to the furnishing of information and assistance in connection with the syndication shall remain in full force and effect until a successful syndication shall have been completed. 
 Each Joint Lead Arranger and Initial Lender hereby notifies you that pursuant to the requirements of the USA Patriot Act (Title III of Pub. L. 107-56
(signed into law October 26, 2001)) (the “Patriot Act”), it is required to obtain, verify and record information that identifies Altria and Philip Morris USA Inc., which information includes Altria’s and Philip Morris USA
Inc.’s names and addresses and other information that will allow such Joint Lead Arranger or Initial Lender to identify Altria and Philip Morris USA Inc. in accordance with the Patriot Act. 
 If the foregoing correctly sets forth our agreement, please indicate your acceptance of the terms hereof and of the Term Sheets, the confidentiality
agreement and the Fee Letters by returning to us executed counterparts hereof and of the Fee Letters not later than 5:00p.m., New York City time, on September 14, 2008. The Initial Lenders’ commitments and the Joint Lead Arrangers’
agreements herein will expire at such time in the event we have not received such executed counterparts in accordance with the immediately preceding sentence. 
 [Signature pages follow.] 
  

 7 

 We are pleased to have been given the opportunity to assist you in connection with this important
financing. 
  

					
	Very truly yours,
		
		 	JPMORGAN CHASE BANK, N.A.,
			
		 	by	 	 /s/ MARIAN N. SCHULMAN

		 		 	Name: Marian N. Schulman
		 		 	Title: Managing Director
		
		 	J.P. MORGAN SECURITIES INC.,
			
		 	by	 	 /s/ THOMAS DELANEY

		 		 	Name: Thomas Delaney
		 		 	Title: Executive Director
		
		 	GOLDMAN SACHS CREDIT PARTNERS L.P.,
			
		 	by	 	 /s/ BRUCE H. MENDELSOHN

		 		 	Name: Bruce H. Mendelsohn
		 		 	Title: Authorized Signatory
		
		 	GOLDMAN SACHS BANK USA,
			
		 	by	 	 /s/ WILLIAM YARBENET

		 		 	Name: William Yarbenet
		 		 	Title: Vice President
		
		 	WILLIAM STREET COMMITMENT CORPORATION (Recourse only to assets of William Street Commitment Corporation), solely to confirm its commitment referred to in the third paragraph of this
Commitment Letter,
			
		 	by	 	 /s/ MARK WALTON

		 		 	Name: Mark Walton
		 		 	Title: Assistant Vice President

  

 8 

					
		 	Accepted and agreed to by:
		 	ALTRIA GROUP, INC.
			
		 	By:	 	 /s/ WILLIAM F. GIFFORD

		 		 	Name: William F. Gifford
		 		 	Title: Vice President and Treasurer
			
		 	Date:	 	 9/7/2008

  

 9 

 Exhibit A 
 ALTRIA GROUP, INC. 
 Summary of Terms and Conditions 
 US$7,000,000,000 364-Day Bridge Loan Facility 
  

							
		 		 	Borrower:	  	Altria Group, Inc. (“Altria”).
				
		 		 	Guarantor:	  	Philip Morris USA Inc.
				
		 		 	Facility:	  	US$7,000,000,000 364-Day Bridge Loan Facility (the “New Bridge Facility”). The terms of the New Bridge Facility will be substantially similar to the terms and conditions of
Altria’s US$4,000,000,000 364-Day Bridge Loan dated as of January 28, 2008 (the “Existing Bridge Facility”) with the exceptions set forth herein, including the following:
				
		 		 		  	(a)        The use of proceeds will be limited to the financing of the acquisition by Altria of all of the outstanding capital stock of UST Inc.
(“Target”) pursuant to an agreement (the “Merger Agreement”) under which a newly created, wholly-owned subsidiary of Altria will merge into Target (the “Acquisition”), and related
transactions.
				
		 		 		  	(b)        Mandatory prepayment and reduction of Commitments is required in an amount equal to the net proceeds of certain Capital Markets Financings (as
defined below), borrowings under Debt Facilities (as defined below) and asset sales.
				
		 		 		  	(c)        The Applicable Interest Rate Margin will be increased and the Facility Fee provided for therein will be replaced by a Commitment Fee at the
Applicable Commitment Fee Rate as described herein.
				
		 		 		  	(d)        Duration fees will be paid.
				
		 		 		  	(e)        Altria’s share repurchase program will be suspended under certain circumstances.
				
		 		 	Purpose:	  	Financing the Acquisition and related transactions.
				
		 		 	 Joint Lead Arrangers
 and
Bookrunners:
	  	J.P. Morgan Securities Inc. (“JPM”) and Goldman Sachs Credit Partners L.P. (“GSCP”).

  

 A-1 

					
		 	Administrative Agents:	  	JPMorgan Chase Bank, N.A. (“JPMCB”) and GSCP.
			
		 	Lenders:	  	A syndicate of lenders, including JPMCB, GSCP, and Goldman Sachs Bank USA (“GSB”), arranged by the Joint Lead Arrangers and Altria.
			
		 	Availability:	  	Fully revolving until maturity; provided that the facility will convert to a single draw term facility in the event that the rating of Altria’s long-term senior unsecured debt is (i)
BBB by Standard & Poor’s or Baa2 by Moody’s and placed on negative credit watch by such rating agency or (ii) is rated below BBB by Standard & Poor’s or Baa2 by Moody’s.
			
		 	Amortization:	  	All principal payable under the New Bridge Facility shall be due in full on the termination date of the New Bridge Facility.
			
		 	Maturity:	  	364 days from the date on which the Acquisition is consummated (the “Closing Date”).
			
		 	Borrowing Options:	  	(a)        Base Rate Advances; and
			
		 		  	(b)        LIBO Rate Advances.
			
		 	Currency of Borrowings:	  	U.S. Dollars.
			
		 	Interest:	  	Base Rate Advances
			
		 		  	The Applicable Interest Rate Margin (as defined below) above the Base Rate. The Base Rate is the higher of (a) JPMCB’s Prime Rate and (b) the Federal Funds Effective Rate plus
 1/2 of 1%. Under Base Rate Advances, interest will be calculated on the basis of a year of 365 or 366 days, as the case may be,
for the actual number of days elapsed and will be payable quarterly.
			
		 		  	LIBO Rate Advances

  

 A-2 

					
		 		  	The Applicable Interest Rate Margin (as defined below) above the applicable London Interbank Offered Rate for 1, 2, 3 or 6 month deposits (plus Reg. D charges, if applicable) as determined by
reference to the applicable Reuters screen or, if such screen is not available, on the average of rates quoted by the reference banks. Under LIBO Rate Advances, interest will be calculated on the basis of a 360-day year for the actual number of days
elapsed and will be payable at the end of the applicable interest period or every 3 months during any interest period exceeding 3 months.
			
		 		  	The “Applicable Interest Rate Margin” means for any LIBO Rate Advance for any interest period a percentage per annum equal to the percentage set forth below determined by reference to
the lower of (i) the rating of Altria’s long-term senior unsecured debt from Standard & Poor’s and (ii) the rating of Altria’s long-term senior unsecured debt from Moody’s, in each case in effect from time to
time during such period:

  

							
	        Rating        	  		  	Applicable Interest
         Rate Margin        
	  	
	A-/A3 or higher	  		  	1.00%	  	
				
	 lower than A-/A3
 and BBB/Baa2
 or higher (but, if
 BBB/Baa2, not
 on negative
 watch)
	  		  	1.50%	  	
				
	 BBB-/Baa3 or
 lower, or
 BBB/Baa2 and
 on negative
 watch
	  		  	2.00%	  	

  

					
		 		  	The Applicable Interest Rate Margin for any Base Rate Advance will equal the Applicable Interest Rate Margin for LIBO Rate Advances minus 1.00% per annum (but in no event less than
zero).
			
		 	Availability:	  	In a minimum amount of US$50,000,000 or an integral multiple of US$1,000,000 in excess thereof, on same business day’s notice for Base Rate Advances and 3 business days’ notice for
LIBO Rate Advances.

  

 A-3 

					
		 	 Reduction, Cancellation
 or
Prepayment:
	  	Optional: Altria may, upon at least 1 business day’s notice, terminate or cancel, in whole or in part, the unused portion of the New Bridge Facility without penalty; provided,
however, that each partial reduction shall be in a minimum amount of US$50,000,000.
			
		 		  	Altria may, upon same business day’s notice for Base Rate Advances and at least 3 business days’ notice for LIBO Rate Advances, prepay in full or in part the Advances without penalty;
provided, however, that Altria shall compensate Lenders for their losses, costs and expenses reasonably incurred as a result of such prepayment; and provided, further, that each partial prepayment shall be in a minimum
amount of US$50,000,000 or the remaining balance if less than US$50,000,000.
			
		 		  	 Mandatory Prepayment:
  
 Advances shall be prepaid, and Commitments reduced, in an aggregate amount equal to 100% of the net proceeds of any (i) Capital Markets Financing Transaction or borrowing
under a Debt Facility (other than borrowings under Altria’s US$3,500,000,000 5-Year Revolving Credit Facility (the “5-Year Revolver”) or a credit agreement replacing the same in an aggregate amount not exceeding the
aggregate commitments under the 5-Year Revolver on the date hereof) or (ii) asset sale outside of Altria’s ordinary course of business (subject to certain exceptions and thresholds to be determined), whether occurring before or after the
Closing Date, other than any such net proceeds up to US$4,000,000,000 that are applied to reduce commitments under the Existing Bridge Facility and, to the extent borrowings are outstanding thereunder, to prepay such borrowings. Prepayments of LIBOR
Rate Advances under this paragraph will be made on the last day of the current interest period for such LIBOR Rate Advances (but in no event more than 60 days after the receipt of the applicable net proceeds). Prepayments of Base Rate Advances will
be made on the third business day following receipt of such net proceeds. Commitments will be reduced at the times such prepayments are made or, in the event there are no outstanding Advances, on the third business day following receipt of such net
proceeds.

  

 A-4 

					
		 		  	 “Capital Markets Financing Transaction” means the sale for cash or cash equivalents, in a public offering registered under the
Securities Act of 1933, as amended, or an offering exempt from registration pursuant to Section 4(2), Rule 144A or Regulation S thereunder, of capital stock issued by Altria or notes, debentures or other debt securities issued by or guaranteed by
Altria having a maturity in excess of one year, offered in the domestic or foreign capital markets.
  
 “Debt Facility” means any debt facility with a term exceeding 364-days entered into by Altria after the date hereof in the commercial bank market, other than the issuance of commercial paper or other
short-term debt programs, or a domestic or foreign working capital facility.

			
		 	Commitment Fee:	  	Altria will pay to each Lender a Commitment Fee at the Applicable Commitment Fee Rate (as defined below) per annum on the undrawn amount of its Commitment, accruing from the Closing Date and
payable quarterly in arrears.
			
		 		  	“Applicable Commitment Fee Rate” means for any period a percentage per annum equal to the percentage per annum set forth below determined by reference to the lower of (i) the
rating of Altria’s long-term senior unsecured debt from Standard & Poor’s and (ii) the rating of Altria’s long-term senior unsecured debt from Moody’s, in each case in effect from time to time during such
period:

  

							
	        Rating        	  		  	Applicable
Commitment Fee
            Rate            	  	
	A-/A3 or higher	  		  	0.1000%	  	
				
	lower than A-/A3
 and BBB/Baa2 or
higher (but, if
 BBB/Baa2, not on
 negative watch)
	  		  	0.1500%	  	
				
	BBB-/Baa3 or
 lower, or
 BBB/Baa2 and on
 negative watch
	  		  	0.3500%	  	

  

 A-5 

					
		 	Duration Fee:	  	 Altria will pay to each Lender a Duration Fee at the Applicable Duration Fee Rate (as defined below) on the amount of its Commitment at the
applicable date.
  
 “Applicable Duration Fee Rate” means for the
relevant date a percentage equal to the percentage set forth below:

  

							
		 		  	Date	  	Fee Rate
				
		 		  	 (a)    Later of 90 days after Closing Date or March 31, 2009
	  	0.2500%
				
		 		  	 (b)    90 days after payment under (a) above
	  	0.5000%
				
		 		  	 (c)    180 days after payment under (a) above
	  	0.7500%

  

					
		 	 Taxes, Reserve
 Requirements,
 Capital Adequacy:
	  	All payments will be made free and clear of any present or future United States tax, withholdings or other deductions whatsoever. Lenders will be subject to mitigation provisions as under the
Existing Bridge Facility. Altria will agree to reimburse Eurodollar reserve requirements applicable to each Lender. Altria will also agree to reimburse certain capital adequacy requirements, subject to a cap of 0.15% per annum of each Lender’s
Commitment.

  

 A-6 

					
		 	 Conditions Precedent
 to Effectiveness
 of Facility:
	  	Conditions precedent: (a) the receipt by the Lenders of (i) satisfactory opinions of counsel to Altria and of counsel to the Administrative Agents as to the transactions contemplated hereby,
(ii) such corporate resolutions, certificates and other documentation from Altria as the Lenders shall reasonably request and (iii) a certificate as to the accuracy of representations and warranties and the absence of defaults after giving effect to
the Acquisition, (b) the substantially simultaneous completion of the Acquisition on the terms set forth in the Merger Agreement (Draft of 9/5/08) made available to the Lenders prior to the date hereof, by the “End Date” referred to
therein, without any waivers of conditions or changes that are material and adverse to Altria or the Lenders (it being agreed that the extension of the “End Date” referred to therein under the conditions and to the date contemplated
thereby will not constitute such a change) that have not been approved by the Administrative Agents (such approval not to be unreasonably withheld or delayed), (c) there not having occurred any “Company Material Adverse Effect”, as defined
in the Merger Agreement (but only to the extent Altria would have the right under the Merger Agreement not to consummate the Acquisition), (d) in connection with the guarantee to be provided by Philip Morris USA Inc., the receipt by the Lenders of
(i) evidence of authority and (ii) a customary legal opinion and (e) payment of fees and expenses then due and payable as agreed.
			
		 	 Conditions Precedent
 to Each
Advance:
	  	After giving effect to the application of the proceeds of all borrowings to be made on the date of such Advance (together with any other resources of Altria applied together therewith), there
shall exist no default under the loan documents, and, except with respect to material adverse change and material adverse litigation, the representations and warranties of Altria therein shall be true and correct immediately prior to, and after
giving effect to, such application.
			
		 	Covenants:	  	Negative, affirmative and financial covenants:
			
		 		  	(a)        Comply with laws (including, without limitation, ERISA).
			
		 		  	(b)        Maintain a ratio of consolidated EBITDA to consolidated interest expense of not less than 4.0 to 1 on a rolling four quarters
basis.

  

 A-7 

					
		 		  	(c)        Maintain a ratio of aggregate consolidated debt to consolidated EBITDA of no greater than 3.0 to 1 on a rolling four quarters
basis.
			
		 		  	(d)        Furnish or make available on the internet at www.altria.com (or any successor or replacement website thereof), which website includes an option
to subscribe to a free service alerting subscribers by e-mail of new SEC filings, if available, or by similar electronic means:
			
		 		  	 (i)        within 60 days after the end of each fiscal quarter, quarterly condensed consolidated balance sheets and
statements of earnings of Altria and its Subsidiaries, certified by the chief financial officer of Altria;

			
		 		  	 (ii)       within 100 days after the end of each fiscal year, audited consolidated financial statements of Altria and its
Subsidiaries; and

			
		 		  	 (iii)       reports to shareholders and Form 8-Ks.

			
		 		  	(e)        Within 5 days after a default or an event of default, furnish a statement of the chief financial officer or treasurer of Altria setting forth
the details and actions taken with respect thereto.
			
		 		  	(f)        Furnish all other historical business and financial information that any Lender through the Administrative Agents may reasonably
request.
			
		 		  	(g)        Furnish within 60 days after the end of each fiscal quarter, a certificate of the chief financial officer or treasurer of Altria certifying
compliance with the financial covenants described in (b) and (c) above.
			
		 		  	(h)        Not create or permit any Major Subsidiary to create any liens, other than certain agreed exceptions (including a basket equal to 15% of
Altria’s consolidated tangible assets).
			
		 		  	(i)        Not merge or consolidate with any person, unless Altria or a Subsidiary organized in the U.S. is the surviving entity and such surviving entity
assumes Altria’s obligations under the New Bridge Facility.

  

 A-8 

					
		 		  	(j)        Suspend share repurchase in the event that (i) aggregate Commitments under the New Bridge Facility and the Existing Bridge Facility exceed
US$3,000,000,000 and (ii) the rating of Altria’s long-term senior unsecured debt is (A) BBB by Standard & Poor’s or Baa2 by Moody’s and placed on negative credit watch by such rating agency or (B) is rated below BBB by Standard
& Poor’s or Baa2 by Moody’s.
			
		 		  	“Subsidiary” means any corporation that is more than 50% owned.
			
		 		  	“Major Subsidiary” means any company organized in the U.S., Canada or certain European countries, 50% or more owned by Altria with assets (after intercompany eliminations)
exceeding US$1,000,000,000.
			
		 	 Representations
 and
Warranties:
	  	 Representations and warranties:
  
 (a)        Altria is a corporation duly organized, validly existing and in good standing in Virginia;

			
		 		  	(b)        the execution, delivery and performance of the loan documents, the borrowings thereunder and the Acquisition are within Altria’s corporate
powers, have been duly authorized and do not contravene its (i) charter or by-laws or (ii) any law, rule, regulation or order of any court or governmental agency or any contractual restriction binding on or affecting it in any material
respect;
			
		 		  	(c)        no authorization and no notice or filing is required with any governmental authority or regulatory body for the execution, delivery and
performance by Altria of the loan documents;
			
		 		  	(d)        the loan documents when delivered are legal, valid and binding obligations of Altria, subject to the effect of bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other laws affecting creditors’ rights generally, and subject, as to enforceability, to general principles of equity and an implied covenant of fair dealing;

  

 A-9 

					
		 		  	(e)        the most recent annual consolidated balance sheet and consolidated statements of earnings of Altria and its Subsidiaries fairly present the
consolidated financial condition of Altria and its Subsidiaries, in accordance with U.S. GAAP. Except as otherwise disclosed in a Form 8-K, there has been no material adverse change in such condition or operations;
			
		 		  	(f)        there is no pending or threatened action or proceeding affecting Altria or any of its Subsidiaries (i) that purports to affect the legality,
validity or enforceability of the loan documents or (ii) except as otherwise disclosed in a Form 10-K, 10-Q or 8-K or in a certificate delivered to the Lenders, that may materially adversely affect the financial condition or operations of Altria and
its Subsidiaries; and
			
		 		  	(g)        none of the proceeds of the Advances will be used in violation of Regulation U of the Board of Governors of the U.S. Federal Reserve System.
Not more than 25% of the assets subject to the limitation on liens referred to under “Covenants” above will consist of margin stock.
			
		 	Events of Default:	  	Events of default:
			
		 		  	(a)        Altria shall fail to pay principal when due and interest or other amounts within 10 days after becoming due, in accordance with the loan
documents;
			
		 		  	(b)        any representation or warranty of Altria in connection with the loan documents shall not be correct in all material respects when made or
confirmed;
			
		 		  	(c)        Altria shall (i) fail to perform certain terms or covenants, or (ii) fail to perform certain other terms or covenants within 15 days or (iii)
fail to perform certain other terms or covenants within 30 days after notice of such failure;
			
		 		  	(d)        Altria or any Major Subsidiary shall default in the payment of interest, premium or principal under certain debt obligations in excess of
US$100,000,000, or any other default under such obligation occurs if the effect of which is to cause acceleration of the maturity of such obligation;

  

 A-10 

					
		 		  	(e)        any bankruptcy, insolvency or similar proceeding shall be instituted by or, unless dismissed or stayed within 60 days, against Altria or any
Major Subsidiary;
			
		 		  	(f)        any judgment in excess of US$100,000,000 shall be entered against Altria or any Major Subsidiary and shall remain unsatisfied or unstayed for a
period of 60 consecutive days; provided that such 60-day period shall be extended for a period not to exceed an additional 120 days if (i) Altria or such Major Subsidiary is contesting such judgment in good faith and (ii) no assets with a fair
market value in excess of US$100,000,000 of Altria or such Major Subsidiary have been levied upon or garnished to satisfy such judgment; and
			
		 		  	(g)        standard ERISA defaults (limited to liability in excess of US$500,000,000 not satisfied or discharged to the satisfaction of the PBGC or the
Required Lenders).
			
		 	Indemnification:	  	Altria agrees to indemnify the Joint Lead Arrangers, Initial Lenders and each Lender and each of their respective affiliates, control persons, directors, officers, employees, attorneys and
agents (each, an “Indemnified Party”) from and against any and all claims, damages, losses, liabilities and expenses (including, without limitation, reasonable fees and disbursements of counsel), which may be incurred by or asserted
against any of them, in each case in connection with or arising out of, or in connection with the preparation for or defense of, any investigation, litigation or proceeding (i) related to the Acquisition or to any other transaction in which any
proceeds of any advance are or are proposed to be applied by Altria, whether or not any such transaction is consummated, and whether or not any Indemnified Party is a party thereto, and (ii) related to the New Bridge Facility, or to any actions or
omissions of Altria, any of its Subsidiaries or any of its or their respective officers, directors, employees or agents, in each case whether or not an Indemnified Party is a party thereto and whether or not such investigation, litigation or
proceeding is brought by Altria or any other person, except for any portion of such claims, damages, losses, liabilities or expenses that is found in a final, non-appealable judgment by a court of competent jurisdiction to have resulted from the
gross negligence or willful misconduct of such Indemnified Party.

  

 A-11 

					
		 	Majority Lenders:	  	50.1%
			
		 	 Assignments and
 Participations:
	  	Lenders may assign their rights and obligations under the loan documents in a minimum amount of US$10,000,000 to one or more financial institutions that are Eligible Assignees (such defined term
in the definitive documentation related to the New Bridge Facility to be conformed to the definition of “Eligible Assignee” in Altria’s 5-Year Revolver). Participations are permitted.
			
		 	Expenses:	  	Altria shall pay the reasonable out-of-pocket expenses of the Administrative Agents (including fees and expenses of counsel referred to below), whether or not the transactions contemplated
hereby are consummated, as well as all expenses of JPMCB, as Administrative Agent, in connection with the administration of the loan documents. Altria shall also pay the expenses of the Lenders in connection with the enforcement of the loan
documents.
			
		 	Governing Law:	  	New York.
			
		 	 Counsel to Joint Lead
 Arrangers and
 Administrative Agents:
	  	Cravath, Swaine & Moore LLP.
			
		 	Counsel to Borrower:	  	Hunton & Williams LLP.

  

 A-12 

 Schedule 1 
 Form of Confidentiality Agreement 
 Subject:        Altria Group, Inc. US$7,000,000,000 364-Day
Bridge Facility (the “New Bridge Facility”) 
 In connection with your possible interest in becoming a Lender in the New
Bridge Facility for Altria Group, Inc. (the “Company”), you will be receiving certain information which is non-public, confidential or proprietary in nature. That information and any other information, regardless of form, whether
oral, written or electronic, concerning the Company, its subsidiaries or the New Bridge Facility furnished to you by the Company, Altria Client Services, Inc. (“Altria Client Services”) or any of their respective Representatives in
connection with the New Bridge Facility (at any time on, before or after the date of this Agreement), together with analyses, compilations or other materials prepared by you or your Representatives which contain or otherwise reflect such information
or your review of, advice concerning or interest in the New Bridge Facility is hereinafter referred to as the “Information.” As used herein, “Representatives” refers to affiliates, directors, officers, employees,
agents, auditors, attorneys, consultants or other advisors, and references to the Company or Altria Client Services shall be deemed to include each of their respective affiliates. In consideration of your receipt of the Information, you agree that:

  

	 	1.	You will not, without the prior written consent of the Company, use, either directly or indirectly, any of the Information except in concert with the Company and Altria Client
Services in connection with the proposed New Bridge Facility or other transactions referred to in paragraph 2 below. It is understood that the Information may be furnished to prospective Lenders under the New Bridge Facility in connection with the
syndication of such Facility under confidentiality agreements substantially in the form hereof or under other procedures (including confidentiality undertakings) agreed upon by you and the Company to ensure the confidentiality of such Information
(such agreement not to be unreasonably withheld or delayed). 

  

	 	2.	You agree to reveal the Information only to your Representatives who need to know the Information for the purpose of evaluating, administering or monitoring the New Bridge Facility
or in connection with any securities offering or other transaction for which you or your affiliates have been retained by the Company or Altria Client Services, who are informed by you of the confidential nature of the Information, and who agree to
be bound by the terms and conditions of this Agreement. You agree to be responsible for any breach of this Agreement by any of your Representatives and to indemnify and hold the Company, Altria Client Services and their respective Representatives
harmless from and against any and all liabilities, claims, causes of action, costs and expenses (including attorney fees and expenses) arising out of the breach of this Agreement by you or your Representatives. 

  

	 	3.	 Without the prior written consent of the Company or Altria Client Services, you shall not disclose to any person (except as otherwise expressly permitted herein)
the fact that the Information has been made available, that discussions are taking 

  

 Schedule 1-1 

	 	 
place between the Company, Altria Client Services and you or any other financial institution concerning the New Bridge Facility, or any of the terms,
conditions or other facts with respect thereto (including the status thereof), or that the New Bridge Facility has been consummated. 

  

	 	4.	This Agreement shall be inoperative as to any portion of the Information that (i) is or becomes generally available to the public on a non-confidential basis through no fault
or action by you or your Representatives, or (ii) is or becomes available to you on a non-confidential basis from a source other than the Company, Altria Client Services or their respective Representatives, which source, to the best of your
knowledge, is not prohibited from disclosing such Information to you by a contractual, legal or fiduciary obligation to the Company, Altria Client Services or their respective Representatives. 

  

	 	5.	You may disclose the Information at the request of any regulatory or supervisory authority having jurisdiction over you; provided that you request confidential treatment of such
Information to the extent permitted by law; provided further, that, insofar as practicable, you notify the Company and Altria Client Services in advance of such disclosure pursuant to the following paragraph. 

  

	 	6.	In the event that you or anyone to whom you transmit the Information pursuant to this Agreement becomes legally compelled to disclose any of the Information or the existence of the
New Bridge Facility, you shall provide the Company and Altria Client Services with notice of such event promptly upon your obtaining knowledge thereof (provided that you are not otherwise prohibited by law from giving such notice) so that the
Company may seek a protective order or other appropriate remedy. In the event that such protective order or other remedy is not obtained, you shall furnish only that portion of the Information that is legally required and shall disclose the
Information in a manner reasonably designed to preserve its confidential nature. 

  

	 	7.	In the event that discussions with you concerning the New Bridge Facility are discontinued or your participation in the New Bridge Facility is otherwise terminated, you shall
deliver to Altria Client Services the copies of the Information that were furnished to you by or on behalf of the Company and represent to Altria Client Services that you have destroyed all other copies thereof, provided that you may maintain copies
of the Information, subject to the terms of this Agreement, as required by law or regulations or document retention policies applicable to you. All of your obligations hereunder and all of the rights and remedies of the Company and Altria Client
Services hereunder shall survive any discontinuance of discussions, termination of your participation or any return or destruction of the Information. 

  

	 	8.	 You acknowledge that disclosure of the Information in violation of the terms of this Agreement could have material adverse consequences that could not be adequately
compensated by money damages alone, and agree that, in the event of any breach by you or your Representatives of this Agreement, the Company, Altria Client Services and their respective Representatives will be entitled to 

  

 Schedule 1-2 

	 	 
equitable relief (including injunction and specific performance) in addition to all other remedies available to them at law or in equity.

  

	 	9.	The obligations set forth in this Agreement shall survive until the earliest of two years from the date of this Agreement or until execution of any agreement between Altria and you
with respect to the Facilities or an agreement which contains confidentiality provisions superseding this Agreement. This Agreement shall govern your confidentiality obligations from the date hereof with respect to Information furnished to you as
described above in connection with the New Bridge Facility, and from the date hereof no prior agreement entered into by you and Altria will apply to such Information. 

  

	 	10.	This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. 

 THIS AGREEMENT IS IN ADDITION TO AND, EXCEPT AS PROVIDED ABOVE, DOES NOT SUPERSEDE THE CONFIDENTIALITY AGREEMENTS CONTAINED IN ANY CREDIT AGREEMENTS OF THE COMPANY OR
ITS AFFILIATES TO WHICH YOU ARE A PARTY. 
 BY ACCEPTING THE INFORMATION, YOU ACKNOWLEDGE THAT YOU AGREE TO THE TERMS AND CONDITIONS SET FORTH HEREIN, AND
YOU AGREE TO BE BOUND BY SUCH TERMS AND CONDITIONS. 
 IT IS UNDERSTOOD AND AGREED THAT THE COMPANY, ALTRIA CLIENT SERVICES AND THEIR RESPECTIVE
REPRESENTATIVES MAY RELY ON THIS EXPRESS AGREEMENT. 
  

 Schedule 1-3 

 Exhibit B 
 ALTRIA GROUP, INC. 
 Summary of Terms and Conditions 
 Amendment to Existing Bridge Facility 
 Terms
used herein and not otherwise defined are being used as defined in the US$4,000,000,000 364-Day Bridge Loan Agreement dated as of January 28, 2008 (the “Existing Bridge Facility”) among Altria Group, Inc. and the Lenders and
agents parties thereto. 
  

					
		 	Borrower:	  	Altria Group, Inc. (“Altria”).
			
		 	Guarantor:	  	Philip Morris USA Inc.
			
		 	 Amendments
 Pricing:
	  	The definition of “Applicable Interest Rate Margin” will be conformed to the definition of the same term in the US$7,000,000,000 364-Day Bridge Loan Facility to be entered into by
Altria and certain agent banks and lenders in connection with Altria’s acquisition of UST Inc. (the “New Bridge Facility”), and the grid under the definition of “Applicable Facility Fee Rate” will be conformed to the
grid under the definition of “Applicable Commitment Fee Rate” in the New Bridge Facility.
			
		 	Maturity:	  	Extendible at Altria’s option for two three-month periods, for up to a total of six months.
			
		 	Financial Ratio:	  	Amendment to Section 5.01(c)(i) to change the ratio of Debt to Consolidated EBITDA from 2.5 to 1 to 3.0 to 1.
			
		 	Consent Fee:	  	 0.125% of the amount of the Commitment of each consenting Lender on the date on which consents by the Required Lenders are received (the
“Consent Date”); such fee shall be earned on the Consent Date and payable within 3 business days of the Consent Date.
  
 0.125% of the amount of the Commitment of each consenting Lender on the earlier of November 14, 2008 and the Closing Date; such fee shall be earned on the Consent Date
and payable on the earlier of November 14, 2008 and the Closing Date.

			
		 	Extension Fee:	  	0.500% of the amount of the Commitment of each Lender on the extension date, per each three month extension.

  

 B-1 

					
		 	Conditions Precedent:	  	 1.     Consent by Lenders (other than JPMCB, GSCP and GSB) with aggregate
Commitments of US$1,500,000,000 or more.
  
 2.     The receipt of (i) satisfactory opinions of counsel to Altria and of counsel to the Administrative Agents as to the transactions contemplated hereby and (ii) such corporate resolution, certificates and other
documentation from Altria as shall reasonably be requested.

  

 B-2 

 Exhibit C 
 ALTRIA GROUP, INC. 
 Summary of Terms and Conditions 
 Amendment to 5-Year Revolver 
 Terms used herein
and not otherwise defined are being used as defined in the US$3,500,000,000 5-Year Revolving Credit Agreement dated as of April 15, 2005 (the “5-Year Revolver”) among Altria Group, Inc. and the Lenders and agents parties
thereto. 
  

					
		 	Borrowers:	  	Altria Group, Inc. (“Altria”) and its wholly-owned subsidiaries as designated from time to time (each, a “Borrower”).
			
		 	Guarantor:	  	Altria.
			
		 	Additional Guarantor:	  	Philip Morris USA Inc.
			
		 	Financial Ratio:	  	Amendment to Section 5.01(c)(i) to change the ratio of Debt to Consolidated EBITDA from 2.5 to 1 to 3.0 to 1.
			
		 	Consent Fee:	  	0.125% of the amount of the Commitment of each consenting Lender on the date on which consents by the Required Lenders are received (the “Revolver Consent Date”); such fee
shall be earned on the Revolver Consent Date and payable within 3 business days after the Revolver Consent Date.
			
		 	Conditions Precedent:	  	 1.     Consent by Required Lenders, which shall include JPMCB and
GSCP.
  
 2.     The
receipt of (i) satisfactory opinions of counsel to Altria and of counsel to the Administrative Agents as to the transactions contemplated hereby and (ii) such corporate resolution, certificates and other documentation from Altria as shall reasonably
be requested.

  

 C-1Amended Novell, Inc. 2000 Stock Plan

 Exhibit 10.1 
 NOVELL, INC. 
 2000 STOCK PLAN 
 Amended April 3, 2003 
 Amended
May 13, 2008 
 1.  Purposes of the Plan. The purposes of this Novell, Inc., 2000 Stock Plan are: 

	 	—	 	 to attract and retain the best available personnel, 

	 	—	 	 to provide additional incentive to Employees, Directors and Consultants, and 

	 	—	 	 to promote the success of the Company’s business. 

 Options granted under the Plan may be Incentive Stock Options or Nonstatutory Stock Options, as determined by the Administrator at the time of grant. Stock Purchase Rights and Common Stock Equivalents may also be granted or awarded under
the Plan. The Administrator may determine that Shares may be issued under the Plan to satisfy the Company’s obligations under the Novell, Inc. Stock-Based Deferred Compensation Plan. 
 2.  Definitions. As used herein, the following definitions shall apply: 
     (a)  “Administrator” means the Board or any of its Committees as shall be administering the Plan, in
accordance with Section 4 of the Plan. 
     (b)  “Annual Retainer Fee” means the
annual fee to which an Outside Director is entitled for serving as a Director during a fiscal year of the Company, but shall not include reimbursement for expenses, fees associated with service on any committee of the Board or fees for other
services provided to the Company. 
     (c)  “Applicable Laws” means the requirements
relating to the administration of stock option plans under U. S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of
any foreign country or jurisdiction where Awards are, or will be, granted under the Plan. 
     (d)  “Award” means an award of Options, Stock Purchase Rights or Common Stock Equivalents pursuant to the terms of the Plan. 
     (e)  “Board” means the Board of Directors of the Company. 
     (f)  “Code” means the Internal Revenue Code of 1986, as amended. 
     (g)  “Committee” means a committee of Directors appointed by the Board in accordance with
Section 4 of the Plan. 
     (h)  “Common Stock” means the common stock of the Company.

  

 -1- 

     (i)  “Common Stock Equivalent” means an unfunded and
unsecured right to receive Shares in the future that may be granted to a Director pursuant to Section 12. 
     (j)  “Common Stock Equivalent Agreement” means a written agreement between the Company and a Director evidencing the terms and conditions of an individual Common Stock Equivalent grant.

     (k)  “Company” means Novell, Inc., a Delaware corporation. 
     (l)  “Consultant” means any person, including an advisor, engaged by the Company or a Parent or
Subsidiary to render services to such entity. 
     (m)  “Director” means a member of the
Board. 
     (n)  “Disability” means total and permanent disability as defined in
Section 22(e)(3) of the Code. 
     (o)  “Employee” means any person, including
Officers and Directors, employed by the Company or any Parent or Subsidiary of the Company. A Service Provider shall not cease to be an Employee in the case of (i) any leave of absence approved by the Company or (ii) transfers between
locations of the Company or between the Company, its Parent, any Subsidiary, or any successor. For purposes of Incentive Stock Options, no such leave may exceed ninety days, unless reemployment upon expiration of such leave is guaranteed by statute
or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, then three (3) months following the 91st day of such leave any Incentive Stock Option held by the Optionee shall cease to be
treated as an Incentive Stock Option and shall be treated for tax purposes as a Nonstatutory Stock Option. Neither service as a Director nor payment of a director’s fee by the Company shall be sufficient to constitute “employment” by
the Company. 
     (p)  “Exchange Act” means the Securities Exchange Act of 1934, as
amended. 
     (q)  “Fair Market Value” means, as of any date, the value of Common Stock
determined as follows: 
 (i)    If the Common Stock is listed on any established stock exchange or a national market
system, including without limitation the Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted
on such exchange or system for the last market trading day prior to the time of determination, as reported in The Wall Street Journal or such other source as the Administrator deems reliable; 
 (ii)    If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair
Market Value of a Share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the last market trading day prior to the day of determination, as reported in The Wall Street Journal or such other source as
the Administrator deems reliable; or 
 (iii)    In the absence of an established market for the Common Stock, the Fair
Market Value shall be determined in good faith by the Administrator. 
  

 -2- 

 (r)  “Incentive Stock Option” means an Option intended to qualify as an
incentive stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder. 
 (s)  “Nonstatutory Stock Option” means an Option not intended to qualify as an Incentive Stock Option. 
 (t)  “Notice of Grant” means a written or electronic notice evidencing certain terms and conditions of an individual Option or Stock Purchase Right grant. The Notice of Grant is part of the Option Agreement.

 (u)  “Officer” means a person who is an officer of the Company within the meaning of Section 16 of the
Exchange Act and the rules and regulations promulgated thereunder. 
 (v)  “Option” means a stock option granted
pursuant to the Plan. 
 (w)  “Option Agreement” means an agreement between the Company and an Optionee
evidencing the terms and conditions of an individual Option grant. The Option Agreement is subject to the terms and conditions of the Plan. 
 (x)  “Optioned Stock” means the Common Stock subject to an Option or Stock Purchase Right. 
 (y)  “Optionee” means the holder of an outstanding Award granted under the Plan. 
 (z)  “Outside Director” means a Director who is not an Employee. 
 (aa)      “Parent” means a “parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code. 
 (bb)      “Plan” means this Novell, Inc., 2000 Stock Plan. 
 (cc)      “Restricted Stock” means shares of Common Stock acquired pursuant to a grant of Stock Purchase
Rights under Section 11 of the Plan. 
 (dd)      “Restricted Stock Purchase Agreement”
means a written agreement between the Company and the Optionee evidencing the terms and restrictions applying to stock purchased under a Stock Purchase Right. The Restricted Stock Purchase Agreement is subject to the terms and conditions of the Plan
and the Notice of Grant. 
 (ee)      “Retirement” means, as applicable, (i) a Service
Provider who is not an Outside Director who leaves the employment of the Company at an age of 65 or older or (ii) a Service Provider who is an Outside Director who leaves the service of the Company at the age of 73. 
 (ff)      “Rule 16b-3” means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as
in effect when discretion is being exercised with respect to the Plan. 
 (gg)      “Section 16(b)” means Section 16(b) of the Exchange Act. 
 (hh)      “Service Provider” means an Employee, Director or Consultant. 
  

 -3- 

 (ii)  “Share” means a share of the Common Stock, as adjusted in accordance
with Section 14 of the Plan. 
 (jj)  “Stock Purchase Right” means the right to purchase Common Stock
pursuant to Section 11 of the Plan, as evidenced by a Notice of Grant. 
 (kk)      “Subsidiary” means a “subsidiary corporation”, whether now or hereafter existing, as defined in Section 424(f) of the Code. 
 3.  Stock Subject to the Plan. Subject to the provisions of Section 14 of the Plan, the maximum aggregate number of Shares which
may be optioned and sold under the Plan is 16,000,000, plus any forfeited Shares. For purposes of this Section 3, ”forfeited Shares” means any Shares issued pursuant to Awards made under the Plan that are forfeited to the Company
pursuant to award terms and conditions, plus any Shares covered by Awards granted under the Plan that are canceled or forfeited. In no event, however, except as to Section 14 of the Plan shall more than 10,000,000 of the Shares eligible for
issuance under the Plan be issued upon the exercise of Incentive Stock Options. The Shares may be authorized, but unissued, or reacquired Common Stock. 
     If an Award expires or becomes unexercisable without having been exercised or converted in full, the unpurchased or unissued Shares which were subject thereto shall become available for future
issuance under the Plan (unless the Plan has terminated); provided, however, that Shares that have actually been issued under the Plan, whether upon exercise of an Option or Stock Purchase Right or conversion of a Common Stock Equivalent, shall not
be returned to the Plan and shall not become available for future issuance under the Plan, except that if Shares of Restricted Stock are repurchased by the Company at their original purchase price, such Shares shall become available for future award
under the Plan. 
     Notwithstanding anything in the Plan to the contrary, the Administrator may provide that a
portion of the Shares authorized for issuance under the Plan pursuant to this Section 3 may be distributed under the Novell, Inc. Stock-Based Deferred Compensation Plan to meet the Company’s obligations with respect to such plan. Any
Shares used to meet the Company’s obligations under the Novell, Inc. Stock-Based Deferred Compensation Plan shall reduce the maximum aggregate number of Shares which may be optioned and sold under the Plan. 
 4.  Administration of the Plan. 
     (a)  Procedure. 
 (i)      Multiple Administrative
Bodies. The Plan may be administered by different Committees with respect to different groups of Service Providers. 
 (ii)      Section 162(m). To the extent that the Administrator determines it to be desirable to qualify Options granted hereunder as “performance-based compensation” within the meaning of
Section 162(m) of the Code, the Plan shall be administered by a Committee of two or more “outside directors” within the meaning of Section 162(m) of the Code. 
 (iii)      Rule 16b-3. To the extent desirable to qualify transactions hereunder as exempt under Rule 16b-3, the
transactions contemplated hereunder shall be structured to satisfy the requirements for exemption under Rule 16b-3. 
  

 -4- 

 (iv)      Other Administration. Other than as provided above, the
Plan shall be administered by (A) the Board or (B) a Committee, which committee shall be constituted to satisfy Applicable Laws. 
     (b)  Powers of the Administrator. Subject to the provisions of the Plan, and in the case of a Committee, subject to the specific duties delegated by the Board to such Committee, the Administrator
shall have the authority, in its discretion: 
     (i)      to determine the Fair Market
Value; 
    (ii)      to select the Service Providers to whom Awards may be granted hereunder;

   (iii)      to determine the number of shares of Common Stock to be covered by each Award
granted hereunder; 
   (iv)      to approve forms of agreement for use under the Plan; 

   (v)      to determine the terms and conditions, not inconsistent with the terms of the Plan, of any
Award granted hereunder. Such terms and conditions include, but are not limited to, the exercise price, the time or times when Options or Stock Purchase Rights may be exercised (which may be based on performance criteria), the time or times when
Common Stock Equivalents may be converted to Shares, any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Awards or the Shares relating thereto, based in each case on such factors as the
Administrator, in its sole discretion, shall determine; 
   (vi)      to construe and interpret the
terms of the Plan and Awards granted pursuant to the Plan; 
  (vii)      to prescribe, amend and rescind
rules and regulations relating to the Plan, including rules and regulations relating to sub-plans established for the purpose of qualifying for preferred treatment under foreign laws; 
 (viii)      to modify or amend each Award (subject to Section 16(c) of the Plan), including the discretionary
authority to extend the post-termination exercisability period of Options longer than is otherwise provided for in the Plan; 
   (ix)      to allow Optionees to satisfy required withholding tax obligations by electing to have the Company withhold from the Shares to be issued upon exercise of an Option or in connection with
Shares acquired pursuant to a Stock Purchase Right or upon the conversion of a Common Stock Equivalent that number of Shares having a Fair Market Value equal to (or less than) the minimum amount required to be withheld. The Fair Market Value of the
Shares to be withheld shall be determined on the date that the amount of tax to be withheld is to be determined. All elections by an Optionee to have Shares withheld for this purpose shall be made in such form and under such conditions as the
Administrator may deem necessary or advisable; 
    (x)      to authorize any person to
execute on behalf of the Company any instrument required to effect an Award previously granted by the Administrator; 
  

 -5- 

 (xi)      to make all other determinations deemed necessary or advisable
for administering the Plan. 
     (c)  Effect of Administrator’s Decision. The
Administrator’s decisions, determinations and interpretations shall be final and binding on all Optionees and any other holders of Awards. 
 5.  Eligibility. Nonstatutory Stock Options and Stock Purchase Rights may be granted to Service Providers. Common Stock Equivalents may be granted to Outside Directors. Incentive Stock Options may be granted only to
Employees. 
 6.  Limitations. 
     (a)  Each Option shall be designated in the Option Agreement as either an Incentive Stock Option or a Nonstatutory Stock Option. However, notwithstanding such designation, to the
extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Optionee during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds
$100,000, such Options shall be treated as Nonstatutory Stock Options. For purposes of this Section 6(a), Incentive Stock Options shall be taken into account in the order in which they were granted. The Fair Market Value of the Shares shall be
determined as of the time the Option with respect to such Shares is granted. 
     (b)  Neither the Plan nor
any Award shall confer upon an Optionee any right with respect to continuing the Optionee’s relationship as a Service Provider with the Company, nor shall they interfere in any way with the Optionee’s right or the Company’s right to
terminate such relationship at any time, with or without cause. 
     (c)  The following limitations shall
apply to grants of Options: 
  (i)      No Service Provider shall be granted, in any fiscal year of the
Company, Options to purchase more than 1,500,000 Shares. 
 (ii)      In connection with his or her initial
service, a Service Provider may be granted Options to purchase up to an additional 1,500,000 Shares which shall not count against the limit set forth in subsection (i) above. 
     (d)  The foregoing limitations shall be adjusted proportionately in connection with any change in the Company’s
capitalization as described in Section 14. 
 7.  Term of Plan. Subject to Section 20 of the Plan, the Plan shall
become effective upon its adoption by the Board. It shall continue in effect for a term of ten (10) years unless terminated earlier under Section 16 of the Plan. 
 8.  Term of Option. The term of each Option shall be stated in the Option Agreement. In the case of an Incentive Stock Option, the term
shall be ten (10) years from the date of grant or such shorter term as may be provided in the Option Agreement. Moreover, in the case of an Incentive Stock Option granted to an Optionee who, at the time the Incentive Stock Option is granted,
owns stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive Stock Option shall be five (5) years from the date of
grant or such shorter term as may be provided in the Option Agreement. 
  

 -6- 

 9.  Option Exercise Price and Consideration. 
     (a)  Exercise Price. The per share exercise price for the Shares to be issued pursuant to exercise of an Option
shall be no less than 100% of Fair Market Value, as shall be determined by the Administrator. 
     (b)  Notwithstanding the foregoing, Options may be granted with a per Share exercise price of less than 100% of the Fair Market Value per Share on the date of grant pursuant to a merger or other corporate
transaction. 
     (c)  Waiting Period and Exercise Dates. At the time an Option is granted, the
Administrator shall fix the period within which the Option may be exercised and shall determine any conditions which must be satisfied before the Option may be exercised. 
     (d)  Form of Consideration. The Administrator shall determine the acceptable form of consideration for
exercising an Option, including the method of payment. In the case of an Incentive Stock Option, the Administrator shall determine the acceptable form of consideration at the time of grant. Such consideration may consist entirely of: 
     (i)    cash; 
    (ii)    check; 
   (iii)    promissory
note; 
   (iv)    other Shares which (A) in the case of Shares acquired upon exercise of an option, have
been owned by the Optionee for more than six months on the date of surrender, and (B) have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Option shall be exercised; 

   (v)    to the extent permitted by applicable law, consideration received by the Company under a cashless
exercise program implemented by the Company in connection with the Plan; 
   (vi)    a reduction in the
amount of any Company liability to the Optionee, including any liability attributable to the Optionee’s participation in any Company-sponsored deferred compensation program or arrangement; 
  (vii)    any combination of the foregoing methods of payment; or 
 (viii)    such other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Laws.

 10.  Exercise of Option. 
     (a)  Procedure for Exercise; Rights as a Shareholder. Any Option granted hereunder shall be exercisable according to the terms of the Plan and at such times and under such
conditions as determined by the Administrator and set forth in the Option Agreement. An Option may not be exercised for a fraction of a Share. 
  

 -7- 

     An Option shall be deemed exercised when the Company receives: (i) written
or electronic notice of exercise (in accordance with the Option Agreement) from the person entitled to exercise the Option, and (ii) full payment for the Shares with respect to which the Option is exercised. Full payment may consist of any
consideration and method of payment authorized by the Administrator and permitted by the Option Agreement and the Plan. Shares issued upon exercise of an Option shall be issued in the name of the Optionee or, if requested by the Optionee, in the
name of the Optionee and his or her spouse. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other
rights as a shareholder shall exist with respect to the Optioned Stock, notwithstanding the exercise of the Option. The Company shall issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a
dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 14 of the Plan. 
     Exercising an Option in any manner shall decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.

     (b)  Termination of Relationship as a Service Provider. If an Optionee ceases to be a Service
Provider, other than upon the Optionee’s Death, Disability, or Retirement, the Optionee may exercise his or her Option within such period of time as is specified in the Option Agreement to the extent that the Option is vested on the date of
termination (but in no event later than the expiration of the term of such Option as set forth in the Option Agreement). In the absence of a specified time in the Option Agreement, the Option shall remain exercisable for 12 months following the
Optionee’s termination. If, on the date of termination, the Optionee is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall revert to the Plan. If, after termination, the Optionee does not
exercise his or her Option within the time specified by the Administrator, the Option shall terminate, and the Shares covered by such Option shall revert to the Plan. 
     (c)  Disability of Optionee. If an Optionee ceases to be a Service Provider as a result of the Optionee’s Disability, the Optionee may exercise his or her Option within
such period of time as is specified in the Option Agreement to the extent the Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth in the Option Agreement). In the absence of
a specified time in the Option Agreement, the Option shall remain exercisable for twelve (12) months following the Optionee’s termination. If, on the date of termination, the Optionee is not vested as to his or her entire Option, the
Shares covered by the unvested portion of the Option shall revert to the Plan. If, after termination, the Optionee does not exercise his or her Option within the time specified herein, the Option shall terminate, and the Shares covered by such
Option shall revert to the Plan. 
     (d)  Death of Optionee. If an Optionee dies while a Service
Provider, the Option may be exercised within such period of time as is specified in the Option Agreement (but in no event later than the expiration of the term of such Option as set forth in the Notice of Grant), by the Optionee’s estate or by
a person who acquires the right to exercise the Option by bequest or inheritance, but only to the extent that the Option is 

  

 -8- 

 
vested on the date of death. Immediately upon an Optionee’s death while a Service Provider, each of the Optionee’s outstanding Options shall become
vested on an accelerated basis with respect to all Shares that would have become vested during the twelve (12) months following such death if Optionee had remained a Service Provider. In the absence of a specified time in the Option Agreement,
the Option shall remain exercisable for twelve (12) months following the Optionee’s termination. If, at the time of death, the Optionee is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option
shall immediately revert to the Plan. The Option may be exercised by the executor or administrator of the Optionee’s estate or, if none, by the person(s) entitled to exercise the Option under the Optionee’s will or the laws of descent or
distribution. If the Option is not so exercised within the time specified herein, the Option shall terminate, and the Shares covered by such Option shall revert to the Plan. 
     (e)  Retirement. 
  (i)      Optionees Other than Outside Directors. Following the Retirement of an Optionee who is not an Outside Director, the Option may be exercised by such Optionee within
such period of time as is specified in the Option Agreement (but in no event later than the expiration of the term of such Option as set forth in the Notice of Grant), but only to the extent that the Option is vested on the date of Retirement.
Immediately upon the Retirement of an Optionee who is not an Outside Director, each of such Optionee’s outstanding Options shall become vested on an accelerated basis with respect to all Shares that would have become vested during the twelve
(12) months following such Retirement if such Optionee had remained a Service Provider. In the absence of a specified time in the Option Agreement, the Option shall remain exercisable for twenty four (24) months following such
Optionee’s Retirement (but in no event later than the expiration of the term of such Option as set forth in the Notice of Grant). If, at the time of Retirement, an Optionee who is not an Outside Director is not vested as to his or her entire
Option, the Shares covered by the unvested portion of the Option shall immediately revert to the Plan. If, after Retirement, an Optionee who is not an Outside Director does not exercise his or her Option within the time specified herein, the Option
shall terminate, and the Shares covered by such Option shall revert to the Plan. 
 (ii)      Optionees Who
Are Outside Directors. Following the Retirement of an Optionee who is an Outside Director, the Option may be exercised by such Optionee within such period of time as is specified in the Option Agreement (but in no event later than the expiration
of the term of such Option as set forth in the Notice of Grant), but only to the extent that the Option is vested on the date of Retirement. Immediately upon the Retirement of an Optionee who is an Outside Director, each of such Optionee’s
outstanding Options shall become vested on an accelerated basis with respect to all Shares that would have become vested following such Retirement if such Optionee had remained a Service Provider. In the absence of a specified time in the Option
Agreement, the Option shall remain exercisable for twenty four (24) months following such Optionee’s Retirement (but in no event later than the expiration of the term of such Option as set forth in the Notice of Grant). If, after
Retirement, an Optionee who is an Outside Director does not exercise his or her Option within the time specified herein, the Option shall terminate, and the Shares covered by such Option shall revert to the Plan. 
     (f)  Buyout Provisions. The Administrator may at any time offer to buy out for a payment in cash
or Shares an Option previously granted based on such terms and conditions as the Administrator shall establish and communicate to the Optionee at the time that such offer is made. 
  

 -9- 

 11.  Stock Purchase Rights. 
     (a)  Rights to Purchase. Stock Purchase Rights may be issued either alone, in addition to, or in tandem with
other Awards granted under the Plan and/or cash awards made outside of the Plan. After the Administrator determines that it will offer Stock Purchase Rights under the Plan, it shall advise the offeree in writing or electronically, by means of a
Notice of Grant, of the terms, conditions and restrictions related to the offer, including the number of Shares that the offeree shall be entitled to purchase, the price to be paid, and the time within which the offeree must accept such offer. The
offer shall be accepted by execution of a Restricted Stock Purchase Agreement in the form determined by the Administrator. 
     (b)  Repurchase Option. Unless the Administrator determines otherwise, the Restricted Stock Purchase Agreement shall grant the Company a repurchase option exercisable upon the voluntary or
involuntary termination of the purchaser’s service with the Company for any reason (including Death, Disability, or Retirement). The purchase price for Shares repurchased pursuant to the Restricted Stock Purchase Agreement shall be the original
price paid by the purchaser and may be paid by cancellation of any indebtedness of the purchaser to the Company. The repurchase option shall lapse at a rate or under such conditions as shall be determined by the Administrator and set forth in the
restricted Stock Purchase Agreement. 
     (c)  Other Provisions. The Restricted Stock Purchase
Agreement shall contain such other terms, provisions and conditions not inconsistent with the Plan as may be determined by the Administrator in its sole discretion. 
     (d)  Rights as a Shareholder. Once the Stock Purchase Right is exercised, the purchaser shall have the rights equivalent to those of a shareholder, and shall be a shareholder
when his or her purchase is entered upon the records of the duly authorized transfer agent of the Company. 
     No
adjustment will be made for a dividend or other right for which the record date is prior to the date the Stock Purchase Right is exercised, except as provided in Section 14 of the Plan. 
 12.  Director Common Stock Equivalents. 
     (a)  Elective Award of Common Stock Equivalents. 
  (i)      Elective Award. An Outside Director may elect no later than March 1st of each calendar year to have up to one hundred percent (100%) of the Director’s Annual Retainer Fee
for the following fiscal year converted to the award of Common Stock Equivalents (“Elective Award”). Such Common Stock Equivalents shall be awarded either (i) on the date that the Annual Retainer Fee is to be paid or (ii) pro
rata on each date that installments of the Annual Retainer Fee are to be paid, whichever is applicable. The number of Common Stock Equivalents to be awarded on each such date shall be based on the Fair Market Value per Share on the date of the
award. 
 (ii)      Conversion. The Common Stock Equivalents subject to an Elective Award shall be
converted into Shares upon the earlier of (i) the termination of the individual’s service as a Director, (ii) a date specified by the Outside Director at the time the Director makes the election to receive the Elective Award, or
(iii) as otherwise provided in Section 14. Upon the conversion of each Elective Award, the Outside Director (or his or her designated beneficiary or estate) shall receive the number of Shares equal to the whole number of Common Stock
Equivalents then credited to the Director’s applicable Elective Award account. 
  

 -10- 

     (b)  Awards in General. Common Stock Equivalents may be awarded
either alone, in addition to, or in tandem with other awards granted under the Plan and/or cash awards made outside of the Plan. An Award of Common Stock Equivalents shall be made pursuant to a Common Stock Equivalent Agreement in such form as is
determined by the Administrator. 
     (c)  Bookkeeping Accounts; Nontransferability. The number of
Common Stock Equivalents awarded pursuant to Section 12(a) shall be credited to a bookkeeping account established in the name of the Director. The Company’s obligation with respect to such Common Stock Equivalents shall not be funded or
secured in any manner. A Director’s right to receive Common Stock Equivalents may not be assigned or transferred, voluntarily or involuntarily, except as expressly provided herein. 
     (d)  Dividends. If the Company pays a cash dividend with respect to the Shares at any time while Common Stock
Equivalents are credited to a Director’s account, there shall be credited to the Director’s account additional Common Stock Equivalents equal to (i) the dollar amount of the cash dividend the Director would have received had he or she
been the actual owner of the Shares to which the Common Stock Equivalents then credited to the Director’s account relate, divided by (ii) the Fair Market Value of one Share on the dividend payment date. The Company will pay the Director a
cash payment in lieu of fractional Common Stock Equivalents on the date of such dividend payment. 
     (e)  Shareholder Rights. A Director (or his or her designated beneficiary or estate) shall not be entitled to any voting or other shareholder rights as a result of the credit of Common Stock
Equivalents to the Director’s account, until certificates representing Shares are delivered to the Director (or his or her designated beneficiary or estate) upon conversion of the Director’s Common Stock Equivalents pursuant to
Section 12(a)(ii). 
 13.  Transferability of Awards. Unless determined otherwise by the Administrator, an Award may
not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Optionee, only by the Optionee. If the
Administrator makes an Award transferable, such Award shall contain such additional terms and conditions as the Administrator deems appropriate. 
 14.  Adjustments Upon Changes in Capitalization, Dissolution, Merger or Asset Sale. 
     (a)  Changes in Capitalization. Subject to any required action by the shareholders of the Company, the number of shares of Common Stock covered by each outstanding Award, the number of Common Stock
Equivalents credited to a Director’s account under Section 12, the number of shares of Common Stock which have been authorized for issuance under the Plan but as to which no Awards have yet been granted or which have been returned to the
Plan upon cancellation or expiration of an Award, the number of shares of Common Stock subject to the Incentive Stock Option limit set forth in Section 3, as well as the price per share of Common Stock covered by each such outstanding Award,
shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other
increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been
“effected without receipt of consideration.” Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares
of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to an Award. 
  

 -11- 

     (b)  Dissolution or Liquidation. In the event of the proposed
dissolution or liquidation of the Company, the Administrator shall notify each Optionee as soon as practicable prior to the effective date of such proposed transaction. The Administrator may, in its discretion, provide (i) for an Optionee to
have the right to exercise his or her Option until ten (10) days prior to such transaction as to all of the Optioned Stock covered thereby, including Shares as to which the Option would not otherwise be exercisable, (ii) that any Company
repurchase option applicable to any Shares purchased upon exercise of an Option or Stock Purchase Right shall lapse as to all such Shares, provided the proposed dissolution or liquidation takes place at the time and in the manner contemplated, and
(iii) that any Common Stock Equivalents credited to a Director’s account under Section 12 shall convert into Shares (as provided in Section 12(a)) immediately prior to the consummation of any such dissolution or liquidation. To
the extent it has not been previously exercised, an Award will terminate immediately prior to the consummation of such proposed action. 
     (c)  Merger or Asset Sale. In the event of a merger of the Company with or into another corporation, or the sale of substantially all of the assets of the Company, each outstanding Award shall be
assumed or an equivalent award substituted by the successor corporation or a Parent or Subsidiary of the successor corporation. In the event that the successor corporation refuses to assume or substitute for such Awards: (i) each Optionee shall
fully vest in and have the right to exercise the Option or Stock Purchase Right as to all of the Optioned Stock, including Shares as to which it would not otherwise be vested or exercisable; (ii) any Company repurchase option applicable to any
Shares acquired upon exercise of an Option or Stock Purchase Right shall lapse as to all such Shares; and (iii) Common Stock Equivalents credited to a Director’s account under Section 12 shall convert into Shares (as provided in
Section 12) immediately prior to the merger or sale of assets. If an Option or Stock Purchase Right becomes fully vested and exercisable in lieu of assumption or substitution in the event of a merger or sale of assets, the Administrator shall
notify the Optionee in writing or electronically that the Option or Stock Purchase Right shall be fully vested and exercisable for a period of fifteen (15) days from the date of such notice, and the Option or Stock Purchase Right shall
terminate upon the expiration of such period. If a Common Stock Equivalent converts to Shares in such event, the Administrator shall notify the Optionee at least fifteen (15) days prior to the consummation of the proposed transaction. For the
purposes of this paragraph, an Award shall be considered assumed if, following the merger or sale of assets, the award confers the right to purchase or receive, for each Share of Optioned Stock subject to the Option or Stock Purchase Right or for
each Common Stock Equivalent immediately prior to the merger or sale of assets, the consideration (whether stock, cash, or other securities or property) received in the merger or sale of assets by holders of Common Stock for each Share held on the
effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the merger
or sale of assets is not solely common stock of the successor corporation or its Parent, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received upon the exercise of the Option or Stock
Purchase Right, for each Share of Optioned Stock subject to the Option or Stock Purchase Right or upon conversion of each Common Stock Equivalent, to be solely common stock of the successor corporation or its Parent equal in fair market value to the
per share consideration received by holders of Common Stock in the merger or sale of assets. 
  

 -12- 

 15.  Date of Grant. The date of grant of an Award shall be, for all purposes, the date
on which the Administrator makes the determination granting such Award, or such other later date as is determined by the Administrator. However, the date of grant of Common Stock Equivalents shall be determined in accordance with Section 12.
Notice of the determination shall be provided to each Optionee within a reasonable time after the date of such grant. 
 16.  Amendment and Termination of the Plan. 
     (a)  Amendment and
Termination. The Board may at any time amend, alter, suspend or terminate the Plan. 
     (b)  Shareholder Approval. The Company shall obtain shareholder approval of any Plan amendment to the extent necessary and desirable to comply with Applicable Laws. 
     (c)  Effect of Amendment or Termination. No amendment, alteration, suspension or termination of the Plan shall
impair the rights of any Optionee, unless mutually agreed otherwise between the Optionee and the Administrator, which agreement must be in writing and signed by the Optionee and the Company. Termination of the Plan shall not affect the
Administrator’s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. 
 17.  Conditions Upon Issuance of Shares. 
     (a)  Legal
Compliance. Shares shall not be issued pursuant to the exercise or conversion of an Award unless the exercise or conversion of such Award and the issuance and delivery of such Shares shall comply with Applicable Laws and shall be further subject
to the approval of counsel for the Company with respect to such compliance. 
     (b)  Investment
Representations. As a condition to the exercise or conversion of an Award, the Company may require the person exercising or converting such Award to represent and warrant at the time of any such exercise or conversion that the Shares are being
purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required. 
 18.  Inability to Obtain Authority. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which
authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite
authority shall not have been obtained. 
 19.  Reservation of Shares. The Company, during the term of this Plan, will at
all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan. 
 20.  Shareholder Approval. The Plan shall be subject to approval by the shareholders of the Company within twelve (12) months after the date the Plan is adopted. Such shareholder approval shall be obtained in the
manner and to the degree required under Applicable Laws. 
  

 -13-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]